Japan Intravenous Iron Drug Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major Region

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report offers an overview of the market trends, drivers, and barriers with respect to the Japan Intravenous Iron Drug market. It also provides a detailed overview of the market of different regions across Hokkaido, Tohoku, Kanto, Chubu, Kinki, Chugoku, Shikoku, Kyushu. The report deep analyzes type and application in Japan Intravenous Iron Drug market. Detailed analysis of key players, along with key growth strategies adopted by Intravenous Iron Drug industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.


    By Player:

    • AMAG Pharmaceuticals, Inc.

    • Luitpold Pharmaceuticals, Inc.

    • Pharmacosmos A/S.

    • Sanofi US

    • Daiichi Sankyo, Inc

    • Allergan Plc


    By Type:

    • Ferric carboxymaltose

    • Iron Sucrose

    • Iron Dextran

    • Others


    By End-User:

    • Nephrology

    • Gynecology & Obstetrics

    • Gastroenterology

    • Oncology

    • Cardiology

    • Others


    By Region:

    • Hokkaido

    • Tohoku

    • Kanto

    • Chubu

    • Kinki

    • Chugoku

    • Shikoku

    • Kyushu

  • 1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Intravenous Iron Drug Market

    • 1.3 Market Segment by Type

      • 1.3.1 Japan Intravenous Iron Drug Market Size and Growth Rate of Ferric carboxymaltose from 2014 to 2026

      • 1.3.2 Japan Intravenous Iron Drug Market Size and Growth Rate of Iron Sucrose from 2014 to 2026

      • 1.3.3 Japan Intravenous Iron Drug Market Size and Growth Rate of Iron Dextran from 2014 to 2026

      • 1.3.4 Japan Intravenous Iron Drug Market Size and Growth Rate of Others from 2014 to 2026

    • 1.4 Market Segment by Application

      • 1.4.1 Japan Intravenous Iron Drug Market Size and Growth Rate of Nephrology from 2014 to 2026

      • 1.4.2 Japan Intravenous Iron Drug Market Size and Growth Rate of Gynecology & Obstetrics from 2014 to 2026

      • 1.4.3 Japan Intravenous Iron Drug Market Size and Growth Rate of Gastroenterology from 2014 to 2026

      • 1.4.4 Japan Intravenous Iron Drug Market Size and Growth Rate of Oncology from 2014 to 2026

      • 1.4.5 Japan Intravenous Iron Drug Market Size and Growth Rate of Cardiology from 2014 to 2026

      • 1.4.6 Japan Intravenous Iron Drug Market Size and Growth Rate of Others from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Hokkaido Intravenous Iron Drug Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Tohoku Intravenous Iron Drug Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Kanto Intravenous Iron Drug Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Chubu Intravenous Iron Drug Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Kinki Intravenous Iron Drug Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Chugoku Intravenous Iron Drug Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Shikoku Intravenous Iron Drug Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Kyushu Intravenous Iron Drug Consumption Market Size and Growth Rate from 2014 to 2026


    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants


    3 Segmentation of Intravenous Iron Drug Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Intravenous Iron Drug by Major Types

      • 3.4.1 Market Size and Growth Rate of Ferric carboxymaltose

      • 3.4.2 Market Size and Growth Rate of Iron Sucrose

      • 3.4.3 Market Size and Growth Rate of Iron Dextran

      • 3.4.4 Market Size and Growth Rate of Others


    4 Segmentation of Intravenous Iron Drug Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Intravenous Iron Drug by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Intravenous Iron Drug in Nephrology

      • 4.4.2 Market Size and Growth Rate of Intravenous Iron Drug in Gynecology & Obstetrics

      • 4.4.3 Market Size and Growth Rate of Intravenous Iron Drug in Gastroenterology

      • 4.4.4 Market Size and Growth Rate of Intravenous Iron Drug in Oncology

      • 4.4.5 Market Size and Growth Rate of Intravenous Iron Drug in Cardiology

      • 4.4.6 Market Size and Growth Rate of Intravenous Iron Drug in Others


    5 Market Analysis by Regions

    • 5.1 Japan Intravenous Iron Drug Production Analysis by Regions

    • 5.2 Japan Intravenous Iron Drug Consumption Analysis by Regions


    6 Hokkaido Intravenous Iron Drug Landscape Analysis

    • 6.1 Hokkaido Intravenous Iron Drug Landscape Analysis by Major Types

    • 6.2 Hokkaido Intravenous Iron Drug Landscape Analysis by Major End-Users


    7 Tohoku Intravenous Iron Drug Landscape Analysis

    • 7.1 Tohoku Intravenous Iron Drug Landscape Analysis by Major Types

    • 7.2 Tohoku Intravenous Iron Drug Landscape Analysis by Major End-Users


    8 Kanto Intravenous Iron Drug Landscape Analysis

    • 8.1 Kanto Intravenous Iron Drug Landscape Analysis by Major Types

    • 8.2 Kanto Intravenous Iron Drug Landscape Analysis by Major End-Users


    9 Chubu Intravenous Iron Drug Landscape Analysis

    • 9.1 Chubu Intravenous Iron Drug Landscape Analysis by Major Types

    • 9.2 Chubu Intravenous Iron Drug Landscape Analysis by Major End-Users


    10 Kinki Intravenous Iron Drug Landscape Analysis

    • 10.1 Kinki Intravenous Iron Drug Landscape Analysis by Major Types

    • 10.2 Kinki Intravenous Iron Drug Landscape Analysis by Major End-Users


    11 Chugoku Intravenous Iron Drug Landscape Analysis

    • 11.1 Chugoku Intravenous Iron Drug Landscape Analysis by Major Types

    • 11.2 Chugoku Intravenous Iron Drug Landscape Analysis by Major End-Users


    12 Shikoku Intravenous Iron Drug Landscape Analysis

    • 12.1 Shikoku Intravenous Iron Drug Landscape Analysis by Major Types

    • 12.2 Shikoku Intravenous Iron Drug Landscape Analysis by Major End-Users


    13 Kyushu Intravenous Iron Drug Landscape Analysis

    • 13.1 Kyushu Intravenous Iron Drug Landscape Analysis by Major Types

    • 13.2 Kyushu Intravenous Iron Drug Landscape Analysis by Major End-Users


    14 Major Players Profiles

    • 14.1 AMAG Pharmaceuticals, Inc.

      • 14.1.1 AMAG Pharmaceuticals, Inc. Company Profile and Recent Development

      • 14.1.2 Market Performance

      • 14.1.3 Product and Service Introduction

    • 14.2 Luitpold Pharmaceuticals, Inc.

      • 14.2.1 Luitpold Pharmaceuticals, Inc. Company Profile and Recent Development

      • 14.2.2 Market Performance

      • 14.2.3 Product and Service Introduction

    • 14.3 Pharmacosmos A/S.

      • 14.3.1 Pharmacosmos A/S. Company Profile and Recent Development

      • 14.3.2 Market Performance

      • 14.3.3 Product and Service Introduction

    • 14.4 Sanofi US

      • 14.4.1 Sanofi US Company Profile and Recent Development

      • 14.4.2 Market Performance

      • 14.4.3 Product and Service Introduction

    • 14.5 Daiichi Sankyo, Inc

      • 14.5.1 Daiichi Sankyo, Inc Company Profile and Recent Development

      • 14.5.2 Market Performance

      • 14.5.3 Product and Service Introduction

    • 14.6 Allergan Plc

      • 14.6.1 Allergan Plc Company Profile and Recent Development

      • 14.6.2 Market Performance

      • 14.6.3 Product and Service Introduction

     

    The List of Tables and Figures (Totals 112 Figures and 160 Tables)

     

    • Figure Japan Intravenous Iron Drug Market Size and Growth Rate of Ferric carboxymaltose from 2014 to 2026

    • Figure Japan Intravenous Iron Drug Market Size and Growth Rate of Iron Sucrose from 2014 to 2026

    • Figure Japan Intravenous Iron Drug Market Size and Growth Rate of Iron Dextran from 2014 to 2026

    • Figure Japan Intravenous Iron Drug Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Market Share by Type in 2014

    • Figure Market Share by Type in 2018

    • Figure Market Share by Type in 2026

    • Figure Japan Intravenous Iron Drug Market Size and Growth Rate of Nephrology from 2014 to 2026

    • Figure Japan Intravenous Iron Drug Market Size and Growth Rate of Gynecology & Obstetrics from 2014 to 2026

    • Figure Japan Intravenous Iron Drug Market Size and Growth Rate of Gastroenterology from 2014 to 2026

    • Figure Japan Intravenous Iron Drug Market Size and Growth Rate of Oncology from 2014 to 2026

    • Figure Japan Intravenous Iron Drug Market Size and Growth Rate of Cardiology from 2014 to 2026

    • Figure Japan Intravenous Iron Drug Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Market Share by End-User in 2014

    • Figure Market Share by End-User in 2018

    • Figure Market Share by End-User in 2026

    • Figure Hokkaido Intravenous Iron Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Tohoku Intravenous Iron Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kanto Intravenous Iron Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Chubu Intravenous Iron Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kinki Intravenous Iron Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Chugoku Intravenous Iron Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Shikoku Intravenous Iron Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kyushu Intravenous Iron Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Intravenous Iron Drug Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2018

    • Figure Market Share of TOP 5 Players in 2018

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Intravenous Iron Drug

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Intravenous Iron Drug by Different Types from 2014 to 2026

    • Table Consumption Share of Intravenous Iron Drug by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Ferric carboxymaltose

    • Figure Market Size and Growth Rate of Iron Sucrose

    • Figure Market Size and Growth Rate of Iron Dextran

    • Figure Market Size and Growth Rate of Others

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Intravenous Iron Drug by Different End-Users from 2014 to 2026

    • Table Consumption Share of Intravenous Iron Drug by Different End-Users from 2014 to 2026

    • Figure Japan Intravenous Iron Drug Market Size and Growth Rate of Nephrology from 2014 to 2026

    • Figure Japan Intravenous Iron Drug Market Size and Growth Rate of Gynecology & Obstetrics from 2014 to 2026

    • Figure Japan Intravenous Iron Drug Market Size and Growth Rate of Gastroenterology from 2014 to 2026

    • Figure Japan Intravenous Iron Drug Market Size and Growth Rate of Oncology from 2014 to 2026

    • Figure Japan Intravenous Iron Drug Market Size and Growth Rate of Cardiology from 2014 to 2026

    • Figure Japan Intravenous Iron Drug Market Size and Growth Rate of Others from 2014 to 2026

    • Table Japan Intravenous Iron Drug Production by Regions

    • Table Japan Intravenous Iron Drug Production Share by Regions

    • Figure Japan Intravenous Iron Drug Production Share by Regions in 2014

    • Figure Japan Intravenous Iron Drug Production Share by Regions in 2018

    • Figure Japan Intravenous Iron Drug Production Share by Regions in 2026

    • Table Japan Intravenous Iron Drug Consumption by Regions

    • Table Japan Intravenous Iron Drug Consumption Share by Regions

    • Figure Japan Intravenous Iron Drug Consumption Share by Regions in 2014

    • Figure Japan Intravenous Iron Drug Consumption Share by Regions in 2018

    • Figure Japan Intravenous Iron Drug Consumption Share by Regions in 2026

    • Table Hokkaido Intravenous Iron Drug Consumption by Types from 2014 to 2026

    • Table Hokkaido Intravenous Iron Drug Consumption Share by Types from 2014 to 2026

    • Figure Hokkaido Intravenous Iron Drug Consumption Share by Types in 2014

    • Figure Hokkaido Intravenous Iron Drug Consumption Share by Types in 2018

    • Figure Hokkaido Intravenous Iron Drug Consumption Share by Types in 2026

    • Table Hokkaido Intravenous Iron Drug Consumption by End-Users from 2014 to 2026

    • Table Hokkaido Intravenous Iron Drug Consumption Share by End-Users from 2014 to 2026

    • Figure Hokkaido Intravenous Iron Drug Consumption Share by End-Users in 2014

    • Figure Hokkaido Intravenous Iron Drug Consumption Share by End-Users in 2018

    • Figure Hokkaido Intravenous Iron Drug Consumption Share by End-Users in 2026

    • Table Tohoku Intravenous Iron Drug Consumption by Types from 2014 to 2026

    • Table Tohoku Intravenous Iron Drug Consumption Share by Types from 2014 to 2026

    • Figure Tohoku Intravenous Iron Drug Consumption Share by Types in 2014

    • Figure Tohoku Intravenous Iron Drug Consumption Share by Types in 2018

    • Figure Tohoku Intravenous Iron Drug Consumption Share by Types in 2026

    • Table Tohoku Intravenous Iron Drug Consumption by End-Users from 2014 to 2026

    • Table Tohoku Intravenous Iron Drug Consumption Share by End-Users from 2014 to 2026

    • Figure Tohoku Intravenous Iron Drug Consumption Share by End-Users in 2014

    • Figure Tohoku Intravenous Iron Drug Consumption Share by End-Users in 2018

    • Figure Tohoku Intravenous Iron Drug Consumption Share by End-Users in 2026

    • Table Kanto Intravenous Iron Drug Consumption by Types from 2014 to 2026

    • Table Kanto Intravenous Iron Drug Consumption Share by Types from 2014 to 2026

    • Figure Kanto Intravenous Iron Drug Consumption Share by Types in 2014

    • Figure Kanto Intravenous Iron Drug Consumption Share by Types in 2018

    • Figure Kanto Intravenous Iron Drug Consumption Share by Types in 2026

    • Table Kanto Intravenous Iron Drug Consumption by End-Users from 2014 to 2026

    • Table Kanto Intravenous Iron Drug Consumption Share by End-Users from 2014 to 2026

    • Figure Kanto Intravenous Iron Drug Consumption Share by End-Users in 2014

    • Figure Kanto Intravenous Iron Drug Consumption Share by End-Users in 2018

    • Figure Kanto Intravenous Iron Drug Consumption Share by End-Users in 2026

    • Table Chubu Intravenous Iron Drug Consumption by Types from 2014 to 2026

    • Table Chubu Intravenous Iron Drug Consumption Share by Types from 2014 to 2026

    • Figure Chubu Intravenous Iron Drug Consumption Share by Types in 2014

    • Figure Chubu Intravenous Iron Drug Consumption Share by Types in 2018

    • Figure Chubu Intravenous Iron Drug Consumption Share by Types in 2026

    • Table Chubu Intravenous Iron Drug Consumption by End-Users from 2014 to 2026

    • Table Chubu Intravenous Iron Drug Consumption Share by End-Users from 2014 to 2026

    • Figure Chubu Intravenous Iron Drug Consumption Share by End-Users in 2014

    • Figure Chubu Intravenous Iron Drug Consumption Share by End-Users in 2018

    • Figure Chubu Intravenous Iron Drug Consumption Share by End-Users in 2026

    • Table Kinki Intravenous Iron Drug Consumption by Types from 2014 to 2026

    • Table Kinki Intravenous Iron Drug Consumption Share by Types from 2014 to 2026

    • Figure Kinki Intravenous Iron Drug Consumption Share by Types in 2014

    • Figure Kinki Intravenous Iron Drug Consumption Share by Types in 2018

    • Figure Kinki Intravenous Iron Drug Consumption Share by Types in 2026

    • Table Kinki Intravenous Iron Drug Consumption by End-Users from 2014 to 2026

    • Table Kinki Intravenous Iron Drug Consumption Share by End-Users from 2014 to 2026

    • Figure Kinki Intravenous Iron Drug Consumption Share by End-Users in 2014

    • Figure Kinki Intravenous Iron Drug Consumption Share by End-Users in 2018

    • Figure Kinki Intravenous Iron Drug Consumption Share by End-Users in 2026

    • Table Chugoku Intravenous Iron Drug Consumption by Types from 2014 to 2026

    • Table Chugoku Intravenous Iron Drug Consumption Share by Types from 2014 to 2026

    • Figure Chugoku Intravenous Iron Drug Consumption Share by Types in 2014

    • Figure Chugoku Intravenous Iron Drug Consumption Share by Types in 2018

    • Figure Chugoku Intravenous Iron Drug Consumption Share by Types in 2026

    • Table Chugoku Intravenous Iron Drug Consumption by End-Users from 2014 to 2026

    • Table Chugoku Intravenous Iron Drug Consumption Share by End-Users from 2014 to 2026

    • Figure Chugoku Intravenous Iron Drug Consumption Share by End-Users in 2014

    • Figure Chugoku Intravenous Iron Drug Consumption Share by End-Users in 2018

    • Figure Chugoku Intravenous Iron Drug Consumption Share by End-Users in 2026

    • Table Shikoku Intravenous Iron Drug Consumption by Types from 2014 to 2026

    • Table Shikoku Intravenous Iron Drug Consumption Share by Types from 2014 to 2026

    • Figure Shikoku Intravenous Iron Drug Consumption Share by Types in 2014

    • Figure Shikoku Intravenous Iron Drug Consumption Share by Types in 2018

    • Figure Shikoku Intravenous Iron Drug Consumption Share by Types in 2026

    • Table Shikoku Intravenous Iron Drug Consumption by End-Users from 2014 to 2026

    • Table Shikoku Intravenous Iron Drug Consumption Share by End-Users from 2014 to 2026

    • Figure Shikoku Intravenous Iron Drug Consumption Share by End-Users in 2014

    • Figure Shikoku Intravenous Iron Drug Consumption Share by End-Users in 2018

    • Figure Shikoku Intravenous Iron Drug Consumption Share by End-Users in 2026

    • Table Kyushu Intravenous Iron Drug Consumption by Types from 2014 to 2026

    • Table Kyushu Intravenous Iron Drug Consumption Share by Types from 2014 to 2026

    • Figure Kyushu Intravenous Iron Drug Consumption Share by Types in 2014

    • Figure Kyushu Intravenous Iron Drug Consumption Share by Types in 2018

    • Figure Kyushu Intravenous Iron Drug Consumption Share by Types in 2026

    • Table Kyushu Intravenous Iron Drug Consumption by End-Users from 2014 to 2026

    • Table Kyushu Intravenous Iron Drug Consumption Share by End-Users from 2014 to 2026

    • Figure Kyushu Intravenous Iron Drug Consumption Share by End-Users in 2014

    • Figure Kyushu Intravenous Iron Drug Consumption Share by End-Users in 2018

    • Figure Kyushu Intravenous Iron Drug Consumption Share by End-Users in 2026

    • Table Company Profile and Development Status of AMAG Pharmaceuticals, Inc.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AMAG Pharmaceuticals, Inc.

    • Figure Sales and Growth Rate Analysis of AMAG Pharmaceuticals, Inc.

    • Figure Revenue and Market Share Analysis of AMAG Pharmaceuticals, Inc.

    • Table Product and Service Introduction of AMAG Pharmaceuticals, Inc.

    • Table Company Profile and Development Status of Luitpold Pharmaceuticals, Inc.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Luitpold Pharmaceuticals, Inc.

    • Figure Sales and Growth Rate Analysis of Luitpold Pharmaceuticals, Inc.

    • Figure Revenue and Market Share Analysis of Luitpold Pharmaceuticals, Inc.

    • Table Product and Service Introduction of Luitpold Pharmaceuticals, Inc.

    • Table Company Profile and Development Status of Pharmacosmos A/S.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pharmacosmos A/S.

    • Figure Sales and Growth Rate Analysis of Pharmacosmos A/S.

    • Figure Revenue and Market Share Analysis of Pharmacosmos A/S.

    • Table Product and Service Introduction of Pharmacosmos A/S.

    • Table Company Profile and Development Status of Sanofi US

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi US

    • Figure Sales and Growth Rate Analysis of Sanofi US

    • Figure Revenue and Market Share Analysis of Sanofi US

    • Table Product and Service Introduction of Sanofi US

    • Table Company Profile and Development Status of Daiichi Sankyo, Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Daiichi Sankyo, Inc

    • Figure Sales and Growth Rate Analysis of Daiichi Sankyo, Inc

    • Figure Revenue and Market Share Analysis of Daiichi Sankyo, Inc

    • Table Product and Service Introduction of Daiichi Sankyo, Inc

    • Table Company Profile and Development Status of Allergan Plc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Allergan Plc

    • Figure Sales and Growth Rate Analysis of Allergan Plc

    • Figure Revenue and Market Share Analysis of Allergan Plc

    • Table Product and Service Introduction of Allergan Plc

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.